MicroRNA-1299 is a negative regulator of STAT3 in colon cancer

Yong Wang1, Zhi Lu2, Ningning Wang3

  • 1The 4th Department of Orthopedic Surgery, Central Hospital Affiliated to Shenyang Medical College, Shenyang, Liaoning, P.R. China.

Oncology Reports
|May 13, 2017
PubMed

Insights

MicroRNA-1299 (miR-1299) is significantly lower in high-grade colon cancer and negatively regulates STAT3. Overexpressing miR-1299 inhibits colon cancer growth, offering potential therapeutic insights.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Signal transducers and activators of transcription (STAT) proteins, particularly STAT3, are crucial in regulating cellular processes and are implicated in colon cancer progression.
  • Colon cancer remains a leading cause of cancer-related mortality worldwide, highlighting the need for novel therapeutic targets.
  • STAT3 plays a critical role in promoting colon cancer cell growth, proliferation, and metastasis.

Purpose of the Study:

  • To investigate the relationship between microRNA-1299 (miR-1299) and STAT3 in colon cancer.
  • To determine the clinical significance of miR-1299 expression in relation to colon cancer stage and patient survival.
  • To evaluate the therapeutic potential of miR-1299 in inhibiting colon cancer progression.

Main Methods:

  • Analysis of miR-1299 expression in 60 colon cancer samples of varying grades.
  • Correlation analysis between miR-1299 and STAT3 expression levels (mRNA and protein).
  • Assessment of overall survival (OS) in patients with different levels of miR-1299 expression.
  • Experimental validation of miR-1299's effect on STAT3 pathway and colon cancer cell growth through overexpression studies.

Main Results:

  • miR-1299 expression was significantly lower in high-grade colon cancer tissues compared to lower grades.
  • A negative correlation was observed between miR-1299 and STAT3 expression, indicating miR-1299 acts as a negative regulator of STAT3.
  • Patients with low miR-1299 levels exhibited shorter overall survival (25.6 months) than those with high miR-1299 levels (28.4 months).
  • Overexpression of miR-1299 successfully downregulated the STAT3 pathway and inhibited colon cancer cell proliferation.

Conclusions:

  • miR-1299 is a potential tumor suppressor microRNA in colon cancer, inversely correlated with STAT3.
  • Reduced miR-1299 expression is associated with advanced TNM stage and poorer prognosis in colon cancer patients.
  • miR-1299 holds promise as a novel molecular therapeutic agent for colon cancer treatment by targeting the STAT3 pathway.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K